ストックスクリーナーアプリを入手
6.041
1.52%
0.131
前日終値:
$5.91
開ける：
$5.95
24時間の取引高:
20,565
Relative Volume:
0.14
時価総額：
$301.78M
収益：
$13.56M
当期純損益:
$-26.97M
株価収益率:
-10.52
EPS:
-0.5742
ネットキャッシュフロー:
$-24.04M
1週間 パフォーマンス:
-7.12%
1か月 パフォーマンス:
-14.53%
6か月 パフォーマンス:
+28.21%
1年 パフォーマンス:
+50.75%
1日の値動き範囲:
$5.86
$6.04
1週間の範囲:
$5.86
$6.755
52週間の値動き範囲:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Compare CV vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.03 | 306.29M | 13.56M | -26.97M | -24.04M | -0.5742 |
ABT
Abbott Laboratories
|
116.11 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
329.97 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.16 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.40 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.19 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-28 | 開始されました | Roth Capital | Buy |
| 2025-07-28 | 開始されました | The Benchmark Company | Speculative Buy |
Capsovision Inc (CV) 最新ニュース
CapsoVision (CV) Earnings Update: The Bottom-Line Figure Trails Its Comparison; Latest Reaction: The Stock Ends Down 0.49%Basic EPS Analysis - Vinanet
CapsoVision Initiates $100 Million At-the-Market Equity Offering with Cantor Fitzgerald - Kalkine Media
CapsoVision Launches $100 Million At-The-Market Offering - TipRanks
CapsoVision launches $100M at-the-market equity program with Cantor Fitzgerald - TradingView
The CapsoVision, Inc. (NASDAQ:CV) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
CapsoVision Earnings Call: Growth, AI Push, Margin Strain - TipRanks
CapsoVision stock rating maintained at Speculative Buy by Benchmark - Investing.com
CapsoVision (CV) Q2 2026 Earnings Call: Umsatz steigt um 10 %, KI-Einführung schreitet voran - TradingKey
CapsoVision Inc (CV) (Q2 2026) Earnings Call Highlights: AI Launch Drives Growth Amid Pricing ... By GuruFocus - Investing.com Canada
CapsoVision (CV) Stock Rich Valuation Meets Widening Losses - Sahm
CapsoVision Q2 Earnings Call Highlights - MarketBeat
CAPSOVISION ($CV) Releases Q2 2026 Earnings - Quiver Quantitative
CapsoVision Reports Q2 2026 Financials: Inventory Growth and Balance Sheet Update - Kalkine Media
CapsoVision Q2 Results: Revenue rises 10% to $3.6 million - scanx.trade
Earnings call transcript: CapsoVision Q2 2026 loss widens as shares fall after hours - Investing.com
CapsoVision Files Mixed Shelf for Up to $250 Million in Securities - marketscreener.com
CapsoVision Q2 2026 Earnings Call Transcript - Benzinga
CapsoVision Launches $100 Million At-the-Market Equity Program - TipRanks
CapsovisionMay Offer Up To $250 Million Of Common Stock, Preferred Stock, Warrants, Rights, And Units - TradingView
CapsoVision (CV) widens losses in H1 2026 and flags going concern risk - Stock Titan
CapsoVision, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CapsoVision, Inc. Provides Revenue Guidance for the Second Half of 2026 - marketscreener.com
CapsoVision Reports Second Quarter 2026 Financial Results - Yahoo Finance
CapsoVision Inc (CV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CapsoVision Inc (CV) Stock News Today - TradingKey
CV Q1 2026 Earnings: Loss Per Share Widens to -$0.15, Shares Still Gain 1.92EPS Revision Trend - Vinanet
CapsoVision launches AI feature for capsule endoscopy abroad By Investing.com - Investing.com Canada
CapsoVision® Announces International Launch of AI Highlights - The Manila Times
CapsoVision launches AI feature for capsule endoscopy abroad - Investing.com
CapsoVision (CV) Jumps Nearly 9% to $7.17, Approaching Key Resistance at $7.53Day Trade Opportunities - dars.gov.et
CV|CapsoVision Inc|Price:6.580|Chg%:-0.120 - tradingkey.com
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026 - GlobeNewswire
CapsoVision Inc. (CV) Q1 2026 Earnings: Wider-Than-Expected Loss Amid Limited DisclosureRevenue Guidance Update - dars.gov.et
CapsoVision (NASDAQ:CV) Major Shareholder Purchases 61,068 Shares of Stock - MarketBeat
CapsoVision Inc (CV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CV|CapsoVision Inc|Price:6.620|Chg%:+0.130 - TradingKey
CapsoVision Inc (CV) Cash Flow - TradingKey
CapsoVision Inc (CV) Balance Sheet - TradingKey
CapsoVision Inc (CV) Income Statement - TradingKey
CapsoVision Inc (CV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CapsoVision Inc (CV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CapsoVision Inc (CV) Valuation: PE, PB & Fair Value Analysis - TradingKey
CV|CapsoVision Inc|Price:6.540|Chg%:+0.050 - TradingKey
CapsoVision Inc (CV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 4 CapsoVision Inc For: 21 July By Investing.com - Investing.com Canada
CapsoVision director Eliyahou Harari buys $410k in company stock - Investing.com
CapsoVision director Eliyahou Harari buys $410k in company stock By Investing.com - Investing.com Nigeria
CapsoVision 10% owner Eliyahou Harari reports purchase of 61,068 common shares for $410,987.64 - Bitget
CapsoVision (CV) Q1 2026 Earnings: EPS Misses Estimates Amid Absent Revenue DisclosureEPS Guidance Update - Vinanet
CapsoVision Inc. (CV) Surges Over 5% – Testing Key Resistance LevelsTurnaround Stocks - dars.gov.et
U.S. Smart Pills Market to Reach US$ 619.10 Million by 2033 as - openPR.com
Capsovision Inc (CV) 財務データ
収益
当期純利益
現金流量
EPS
0.76%
0.22%
大文字化:
|
ボリューム (24 時間):